589 related articles for article (PubMed ID: 18801863)
1. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.
Cade WT
Phys Ther; 2008 Nov; 88(11):1322-35. PubMed ID: 18801863
[TBL] [Abstract][Full Text] [Related]
2. Vascular risk: diabetes.
Collinson DJ; Rea R; Donnelly R
Vasc Med; 2004 Nov; 9(4):307-10. PubMed ID: 15678624
[No Abstract] [Full Text] [Related]
3. Diabetes and stroke: part one--risk factors and pathophysiology.
Baliga BS; Weinberger J
Curr Cardiol Rep; 2006 Feb; 8(1):23-8. PubMed ID: 16507231
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms for early microvascular injury in obesity and type II diabetes.
Bohlen HG
Curr Hypertens Rep; 2004 Feb; 6(1):60-5. PubMed ID: 14972096
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
Soro-Paavonen A; Zhang WZ; Venardos K; Coughlan MT; Harris E; Tong DC; Brasacchio D; Paavonen K; Chin-Dusting J; Cooper ME; Kaye D; Thomas MC; Forbes JM
J Hypertens; 2010 Apr; 28(4):780-8. PubMed ID: 20186099
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.
Tseng LN; Tseng YH; Jiang YD; Chang CH; Chung CH; Lin BJ; Chuang LM; Tai TY; Sheu WH
J Formos Med Assoc; 2012 Nov; 111(11):625-36. PubMed ID: 23217598
[TBL] [Abstract][Full Text] [Related]
7. Does microvascular disease predict macrovascular events in type 2 diabetes?
Rosenson RS; Fioretto P; Dodson PM
Atherosclerosis; 2011 Sep; 218(1):13-8. PubMed ID: 21763654
[TBL] [Abstract][Full Text] [Related]
8. Gestational diabetes, pregnancy hypertension, and late vascular disease.
Carpenter MW
Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
[TBL] [Abstract][Full Text] [Related]
9. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
10. In utero origins of adult insulin resistance and vascular dysfunction.
Thompson JA; Regnault TR
Semin Reprod Med; 2011 May; 29(3):211-24. PubMed ID: 21710397
[TBL] [Abstract][Full Text] [Related]
11. Optimizing cardiovascular outcomes in diabetes mellitus.
Sobel BE
Am J Med; 2007 Sep; 120(9 Suppl 2):S3-11. PubMed ID: 17826044
[TBL] [Abstract][Full Text] [Related]
12. Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players.
Alexandru N; Badila E; Weiss E; Cochior D; Stępień E; Georgescu A
Biochem Biophys Res Commun; 2016 Mar; 472(1):1-10. PubMed ID: 26891868
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
[TBL] [Abstract][Full Text] [Related]
14. High fat diet induces central obesity, insulin resistance and microvascular dysfunction in hamsters.
Costa RR; Villela NR; Souza Md; Boa BC; Cyrino FZ; Silva SV; Lisboa PC; Moura EG; Barja-Fidalgo TC; Bouskela E
Microvasc Res; 2011 Nov; 82(3):416-22. PubMed ID: 21889944
[TBL] [Abstract][Full Text] [Related]
15. Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus.
Carter AM; Grant PJ
Diabet Med; 1997 Jun; 14(6):423-32. PubMed ID: 9212306
[TBL] [Abstract][Full Text] [Related]
16. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
[TBL] [Abstract][Full Text] [Related]
17. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.
Rahman S; Rahman T; Ismail AA; Rashid AR
Diabetes Obes Metab; 2007 Nov; 9(6):767-80. PubMed ID: 17924861
[TBL] [Abstract][Full Text] [Related]
18. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
Krentz AJ; Clough G; Byrne CD
J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.
Madonna R; De Caterina R
Vascul Pharmacol; 2011; 54(3-6):68-74. PubMed ID: 21453786
[TBL] [Abstract][Full Text] [Related]
20. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia.
DeRubertis BG; Pierce M; Ryer EJ; Trocciola S; Kent KC; Faries PL
J Vasc Surg; 2008 Jan; 47(1):101-8. PubMed ID: 18178459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
